Fig. 4: Luteolin inhibited the activation of AIM2 inflammasome in vitro.
From: Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment
a Western blot analysis for the protein expressions of AIM2, pro-caspase-1, caspase-1 p10, pro-IL-1β, and IL-1β in A549 and H460 cells. b RT-qPCR detection for the mRNA expressions of AIM2, caspase-1, and IL-1β. c Immunofluorescence analysis of endogenous ASC in cells treated by luteolin for 24 h (scale bar = 25 μm). *P < 0.05, **P < 0.01, ***P < 0.001 vs control
